Flibanserin
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB04908 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 25 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | familial generalized lentiginosis | KG + DL |
| 2 | acromelanosis | KG + DL |
| 3 | congenital multiple café-au-lait macules-increased sister chromatid exchange syndrome | KG + DL |
| 4 | leukonychia totalis-acanthosis-nigricans-like lesions-abnormal hair syndrome | KG + DL |
| 5 | rhabdoid tumor | KG + DL |
| 6 | pulmonary arteriovenous malformation (disease) | KG + DL |
| 7 | pulmonary arterial hypertension associated with congenital heart disease | KG + DL |
| 8 | osteopathia striata-pigmentary dermopathy-white forelock syndrome | KG + DL |
| 9 | gastrocutaneous syndrome | KG + DL |
| 10 | peripheral nerve schwannoma | KG + DL |
| 11 | Moynahan syndrome | KG + DL |
| 12 | pulmonary arterial hypertension associated with chronic hemolytic anemia | KG + DL |
| 13 | pulmonary arterial hypertension associated with schistosomiasis | KG + DL |
| 14 | pulmonary arterial hypertension associated with connective tissue disease | KG + DL |
| 15 | pulmonary arterial hypertension associated with HIV infection | KG + DL |
| 16 | schwannoma of twelfth cranial nerve | KG + DL |
| 17 | sympathetic neurilemmoma | KG + DL |
| 18 | trigeminal schwannoma | KG + DL |
| 19 | microcystic/reticular schwannoma | KG + DL |
| 20 | pulmonary arterial hypertension | KG + DL |
| 21 | hypotrichosis simplex of the scalp | KG + DL |
| 22 | Dravet syndrome | KG + DL |
| 23 | neurofibromatosis | KG + DL |
| 24 | congenital hypotrichosis milia | KG + DL |
| 25 | diffuse alopecia areata | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.